Epilepsy Talk
What’s Really In Your Meds?
March 10, 2020
22 Comments
22 Comments
“As Americans become more concerned about quality issues with prescription medications made abroad, one company is trying to offer an additional layer of reassurance — by doing chemical analysis before dispensing drugs to patients…”
Posted in Epilepsy, Medication Issues, News, Research
Tags: anti-convulsant medications, chemical analysis, China, consistency, contaminents, correct dosage, FDA, generics and name brand drugs, global drug supply, India, level of quality control, media attention, pharmaceutical supply chain, prescription medications, quality data, quality issues, quality scores, ranking manufacturers, relapses, safety, side effects, third-party check, variability
Tags: anti-convulsant medications, chemical analysis, China, consistency, contaminents, correct dosage, FDA, generics and name brand drugs, global drug supply, India, level of quality control, media attention, pharmaceutical supply chain, prescription medications, quality data, quality issues, quality scores, ranking manufacturers, relapses, safety, side effects, third-party check, variability
Neurologist or Epileptologist — Who is Best for YOU?
June 2, 2013
24 Comments
24 Comments
Do you have a neurologist? Or is your epilepsy followed by your primary care physician? Should you see an epileptologist?
There is no strict definition of what an epileptologist is. (Although the term was first made popular by William Spratling, now regarded as North America’s first epileptologist.)
Generally speaking, an epileptologist is a neurologist who has a specific interest in, and focuses on, epilepsy.
About the author
